Advertisement

Familial Cancer

, Volume 15, Issue 4, pp 601–606 | Cite as

A mutation of the succinate dehydrogenase B gene in a Korean family with paraganglioma

  • Borum Sagong
  • Young Joon Seo
  • Hyun-Jin Lee
  • Mi Joo Kim
  • Un-Kyung KimEmail author
  • In Seok MoonEmail author
Original Article

Abstract

Familial paraganglioma (PGL) is a dominantly inherited disorder characterized by development of PGLs in the head and neck region. Germline mutations in genes coding for succinate dehydrogenase (SDH) subunits D, B, and C (SDHD, SDHB, SDHC) are found in almost all familial PGL patients. A 19-year-old female presented with pulsatile tinnitus and a reddish pulsating mass in the external auditory canal, and her mother complained of similar symptoms. Paraganglioma was found in both patients and was surgically removed. We report a case of germline SDHB mutation. This mutation was a deletion of thymine at nucleotide position 757 in exon 7 of the SDHB gene (c.757delT).

Keywords

Germ-line mutation Succinate dehydrogenase Paraganglioma 

Notes

Acknowledgments

This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (HI14C2119 to U.K.K). This work was also supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, Information and Communications Technology (ICT) and Future Planning (2015R1A2A2A01003438 to U.K.K) and NRF grant funded by the Korean government (NRF-2014R1A1A2058141 to I.S.M).

Compliance with ethical standards

Conflict of interest

None.

References

  1. 1.
    van der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ, Schmidt PH, van de Kamp JJ (1989) Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet 2(8675):1291–1294. doi: 10.1016/S0140-6736(89)91908-9 PubMedGoogle Scholar
  2. 2.
    Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K (2011) Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem 57(3):411–420. doi: 10.1373/clinchem.2010.153320 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Schiavi F, Boedeker CC, Bausch B, Peczkowska M, Gomez CF, Strassburg T, Pawlu C, Buchta M, Salzmann M, Hoffmann MM, Berlis A, Brink I, Cybulla M, Muresan M, Walter MA, Forrer F, Valimaki M, Kawecki A, Szutkowski Z, Schipper J, Walz MK, Pigny P, Bauters C, Willet-Brozick JE, Baysal BE, Januszewicz A, Eng C, Opocher G, Neumann HP (2005) Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 294(16):2057–2063. doi: 10.1001/jama.294.16.2057 CrossRefPubMedGoogle Scholar
  4. 4.
    Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skoldberg F, Husebye ES, Eng C, Maher ER (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69(1):49–54. doi: 10.1086/321282 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Lee JH, Barich F, Karnell LH, Robinson RA, Zhen WK, Gantz BJ, Hoffman HT (2002) National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer 94(3):730–737. doi: 10.1002/cncr.10252 CrossRefPubMedGoogle Scholar
  6. 6.
    Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292(8):943–951. doi: 10.1001/jama.292.8.943 CrossRefPubMedGoogle Scholar
  7. 7.
    Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN, Richard CW 3rd, Cornelisse CJ, Devilee P, Devlin B (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287(5454):848–851. doi: 10.1126/science.287.5454.848 CrossRefPubMedGoogle Scholar
  8. 8.
    Baysal BE (2008) Clinical and molecular progress in hereditary paraganglioma. J Med Genet 45(11):689–694. doi: 10.1136/jmg.2008.058560 CrossRefPubMedGoogle Scholar
  9. 9.
    Pasini B, Stratakis CA (2009) SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med 266(1):19–42. doi: 10.1111/j.1365-2796.2009.02111.x CrossRefPubMedGoogle Scholar
  10. 10.
    Lee SA, Kim EH, Lee YM, Lee W, Min WK, Lee YJ, Huh JR, Lee WJ (2010) A novel mutation of the succinate dehydrogenase B gene in a Korean family with pheochromocytoma. Fam Cancer 9(4):643–646. doi: 10.1007/s10689-010-9359-0 CrossRefPubMedGoogle Scholar
  11. 11.
    Bayley JP, Devilee P, Taschner PE (2005) The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med Genet 6:39. doi: 10.1186/1471-2350-6-39 CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Leiden Open Variation Database A (2010) Netherlands. http://chromium.lovd.nl/lovd_sdh/home.php?select_db=SDHB. Accessed 25 May
  13. 13.
    Neumann HP, Erlic Z, Boedeker CC, Rybicki LA, Robledo M, Hermsen M, Schiavi F, Falcioni M, Kwok P, Bauters C, Lampe K, Fischer M, Edelman E, Benn DE, Robinson BG, Wiegand S, Rasp G, Stuck BA, Hoffmann MM, Sullivan M, Sevilla MA, Weiss MM, Peczkowska M, Kubaszek A, Pigny P, Ward RL, Learoyd D, Croxson M, Zabolotny D, Yaremchuk S, Draf W, Muresan M, Lorenz RR, Knipping S, Strohm M, Dyckhoff G, Matthias C, Reisch N, Preuss SF, Esser D, Walter MA, Kaftan H, Stover T, Fottner C, Gorgulla H, Malekpour M, Zarandy MM, Schipper J, Brase C, Glien A, Kuhnemund M, Koscielny S, Schwerdtfeger P, Valimaki M, Szyfter W, Finckh U, Zerres K, Cascon A, Opocher G, Ridder GJ, Januszewicz A, Suarez C, Eng C (2009) Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res 69(8):3650–3656. doi: 10.1158/0008-5472.CAN-08-4057 CrossRefPubMedGoogle Scholar
  14. 14.
    Ricketts CJ, Forman JR, Rattenberry E, Bradshaw N, Lalloo F, Izatt L, Cole TR, Armstrong R, Kumar VK, Morrison PJ, Atkinson AB, Douglas F, Ball SG, Cook J, Srirangalingam U, Killick P, Kirby G, Aylwin S, Woodward ER, Evans DG, Hodgson SV, Murday V, Chew SL, Connell JM, Blundell TL, Macdonald F, Maher ER (2010) Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 31(1):41–51. doi: 10.1002/humu.21136 CrossRefPubMedGoogle Scholar
  15. 15.
    van Hulsteijn LT, Dekkers OM, Hes FJ, Smit JW, Corssmit EP (2012) Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis. J Med Genet 49(12):768–776. doi: 10.1136/jmedgenet-2012-101192 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2016

Authors and Affiliations

  1. 1.Department of Biology, College of Natural SciencesKyungpook National UniversityDaeguRepublic of Korea
  2. 2.Department of OtorhinolaryngologyYonsei University College of MedicineSeoulRepublic of Korea
  3. 3.School of Life Sciences, BK21 Plus KNU Creative BioResearch GroupKyungpook National UniversityDaeguRepublic of Korea

Personalised recommendations